Robert Puckrin

646 total citations
29 papers, 370 citations indexed

About

Robert Puckrin is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Robert Puckrin has authored 29 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 8 papers in Genetics. Recurrent topics in Robert Puckrin's work include Lymphoma Diagnosis and Treatment (13 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and CAR-T cell therapy research (5 papers). Robert Puckrin is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and CAR-T cell therapy research (5 papers). Robert Puckrin collaborates with scholars based in Canada, India and Japan. Robert Puckrin's co-authors include Pascal Reynier, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay, Douglas A. Stewart, Anthea Peters, Sunita Ghosh, Sameena Iqbal, Carolyn Owen and A. Zidulka and has published in prestigious journals such as Blood, British Journal of Haematology and JAMA Internal Medicine.

In The Last Decade

Robert Puckrin

22 papers receiving 365 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Puckrin 154 78 69 68 58 29 370
Meryl C. Nath 100 0.6× 33 0.4× 95 1.4× 66 1.0× 29 0.5× 13 440
Predrag Miljić 64 0.4× 38 0.5× 79 1.1× 52 0.8× 18 0.3× 57 510
Mariela Varsavsky 82 0.5× 77 1.0× 91 1.3× 47 0.7× 129 2.2× 40 379
Matthias Schuetz 170 1.1× 36 0.5× 23 0.3× 52 0.8× 43 0.7× 14 444
Diana Ly 137 0.9× 34 0.4× 35 0.5× 115 1.7× 42 0.7× 6 385
Mitsuru Ichii 59 0.4× 64 0.8× 26 0.4× 43 0.6× 30 0.5× 16 332
Raiz Ahmad Misgar 216 1.4× 28 0.4× 116 1.7× 94 1.4× 26 0.4× 35 427
Ji Young Joung 315 2.0× 37 0.5× 41 0.6× 126 1.9× 29 0.5× 23 428
Kairui Jin 49 0.3× 51 0.7× 63 0.9× 76 1.1× 97 1.7× 21 394
Özcan Yıldız 85 0.6× 22 0.3× 44 0.6× 72 1.1× 126 2.2× 34 321

Countries citing papers authored by Robert Puckrin

Since Specialization
Citations

This map shows the geographic impact of Robert Puckrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Puckrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Puckrin more than expected).

Fields of papers citing papers by Robert Puckrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Puckrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Puckrin. The network helps show where Robert Puckrin may publish in the future.

Co-authorship network of co-authors of Robert Puckrin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Puckrin. A scholar is included among the top collaborators of Robert Puckrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Puckrin. Robert Puckrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Puckrin, Robert, Carolyn Owen, & Anthea Peters. (2024). Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia. European Journal Of Haematology. 114(4). 636–640.
4.
Puckrin, Robert, Neil Chua, Carolyn Owen, et al.. (2023). Consolidative Autotransplantation Achieves High Cure Rates in Adverse-Risk Large B Cell Lymphoma. Transplantation and Cellular Therapy. 29(12). 763.e1–763.e5.
5.
Puckrin, Robert, Kareem Jamani, & Víctor H. Jiménez‐Zepeda. (2023). Long‐term survivorship care after CAR‐T cell therapy. European Journal Of Haematology. 112(1). 41–50. 12 indexed citations
6.
Puckrin, Robert, Mona Shafey, & Jan Storek. (2023). The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review. Frontiers in Oncology. 12. 1105779–1105779. 5 indexed citations
7.
Puckrin, Robert, Catherine Leyshon, Peter Duggan, et al.. (2023). Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance. Cytotherapy. 25(10). 1101–1106.
8.
Puckrin, Robert, Carolyn Owen, Peter Duggan, et al.. (2023). Improving the Utilization and Tolerability of Thiotepa-Based Autologous Stem Cell Transplantation in Primary CNS Lymphoma. Blood. 142(Supplement 1). 3595–3595.
9.
Ghosh, Sunita, Catherine Leyshon, Deonne Dersch‐Mills, et al.. (2022). Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant. Clinical Transplantation. 36(8). e14732–e14732. 4 indexed citations
10.
Puckrin, Robert, et al.. (2022). Favorable Outcomes with R-CHOP Induction and Consolidative Autologous Stem Cell Transplantation for Double-Hit Lymphoma. Transplantation and Cellular Therapy. 28(11). 762.e1–762.e4. 1 indexed citations
11.
Tripathi, Gaurav, Poonam Dharmani‐Khan, Robert Puckrin, et al.. (2022). Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease. Cytotherapy. 24(12). 1225–1231. 2 indexed citations
12.
Williamson, Tyler, Na Li, Faisal M. Khan, et al.. (2022). Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder. Transplantation and Cellular Therapy. 29(1). 43.e1–43.e8. 9 indexed citations
13.
Puckrin, Robert, Douglas A. Stewart, & Mona Shafey. (2022). Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis. Transplantation and Cellular Therapy. 28(4). 218.e1–218.e4. 6 indexed citations
14.
Puckrin, Robert, Sunita Ghosh, Anthea Peters, & Douglas A. Stewart. (2021). Inferior outcomes with R-CEOP for patients with diffuse large B-cell lymphoma and cardiovascular comorbidities. Leukemia & lymphoma. 63(3). 583–590. 7 indexed citations
15.
Puckrin, Robert, et al.. (2021). Ineffectiveness of high‐dose methotrexate for prevention of CNS relapse in diffuse large B‐cell lymphoma. American Journal of Hematology. 96(7). 764–771. 35 indexed citations
16.
Puckrin, Robert, Eshetu G. Atenafu, Jaime O. Claudio, et al.. (2020). Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. Haematologica. 106(1). 56–63. 28 indexed citations
17.
Puckrin, Robert, et al.. (2018). SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetologica. 55(5). 503–514. 188 indexed citations
18.
Puckrin, Robert, Eshetu G. Atenafu, Jaime O. Claudio, et al.. (2018). Molecular Residual Disease Monitoring Provides Insufficient Lead-Time to Prevent Morphologic Relapse in the Majority of Patients with Core-Binding Factor AML. Blood. 132(Supplement 1). 436–436. 1 indexed citations
19.
Puckrin, Robert, et al.. (2017). Intravascular large B‐cell lymphoma presenting as Richter's syndrome with cerebral involvement in a patient with chronic lymphocytic leukemia. Clinical Case Reports. 5(9). 1444–1449. 3 indexed citations
20.
Puckrin, Robert, et al.. (2015). Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea. International Urology and Nephrology. 47(11). 1839–1845. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meryl C. Nath Breakdown of academic impact, for papers by Predrag Miljić Breakdown of academic impact, for papers by Mariela Varsavsky Breakdown of academic impact, for papers by Matthias Schuetz Breakdown of academic impact, for papers by Diana Ly Breakdown of academic impact, for papers by Mitsuru Ichii Breakdown of academic impact, for papers by Raiz Ahmad Misgar Breakdown of academic impact, for papers by Ji Young Joung Breakdown of academic impact, for papers by Kairui Jin Breakdown of academic impact, for papers by Özcan Yıldız
Rankless by CCL
2026